Walleye Capital
HLVX

Walleye Capital’s HilleVax HLVX Stock Holding History

Walleye Capital’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-142,182
Closed -$2.36M – 5766
2024
Q1 		$2.36M Sell
142,182
-62,476
-31% -$1,000K ﹤0.01% 1880
2023
Q4 		$3.28M Buy
+204,658
New +$2.72M 0.01% 1401

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return

Walleye Capital's HLVX Position: Q2 2024 in Review

Walleye Capital sold out of HilleVax (HLVX) in Q2 2024, closing a stake of 142,182 shares — an estimated $2.36M sold.

Walleye Capital first reported a position in HLVX in Q4 2023 and held it in 2 quarters. The position peaked at $3.28M in Q4 2023. 93 funds tracked by Wall St. Rank hold HLVX as of Q2 2024.

  • Walleye Capital reported no remaining HilleVax position as of Q2 2024 after selling out during the quarter.
  • Walleye Capital sold 142,182 HilleVax shares in Q2 2024, an estimated $2.36M.
  • Walleye Capital first reported a position in HilleVax in Q4 2023 and held it in 2 quarters.
  • Walleye Capital's HilleVax position peaked at $3.28M in Q4 2023.
  • 93 funds tracked by Wall St. Rank held HilleVax as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.